Filing Details
- Accession Number:
- 0001209191-15-003501
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-09 17:45:47
- Reporting Period:
- 2015-01-08
- Filing Date:
- 2015-01-09
- Accepted Time:
- 2015-01-09 17:45:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1069899 | Phibro Animal Health Corp | PAHC | Pharmaceutical Preparations (2834) | 131840497 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1363803 | L.p. Mayflower | 22 Grenville Street St. Helier Y9 JE4 8PX | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2015-01-08 | 57,673 | $0.00 | 1,789,719 | No | 4 | S | Indirect | See Footnote |
| Class A Common Stock | Disposition | 2015-01-09 | 61,971 | $0.00 | 1,727,748 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
Footnotes
- Shares were sold in multiple transactions at a weighted average price of $30.2034 per share at prices ranging from $29.83 to $30.44. The reporting persons undertake to provide Phibro Animal Health Corp (the "Issuer"),any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- Shares were sold in multiple transactions at a weighted average price of $30.157 per share at prices ranging from $29.90 to $30.39. The reporting persons undertake to provide the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- Shares are directly held by Mayflower LP ("Mayflower"). Investment and divestment decisions with respect to the shares held by Mayflower are made by the investment committee of 3i Investments plc, which is themanager of Mayflower. 3i Investments plc is an indirect wholly owned subsidiary of 3i Group plc, a public company listed on the London Stock Exchange. 3i Investments plc is advised by 3i Corporation, which is also an indirect wholly owned subsidiary of 3i Group plc.
Billionaire Hedge Funds
